-
1Academic Journal
Συγγραφείς: I. A. Khripun, R. S. Ismailov, I. I. Belousov, Kh. S. Ibishev, M. I. Kogan, И. А. Хрипун, Р. С. Исмаилов, И. И. Белоусов, Х. С. Ибишев, М. И. Коган
Συνεισφορές: The research was supported by the non-commercial federal state scientific organization — the Russian Science Foundation (FundRef ID 10.13039/501100006769), under grant No. 14-25-00052., Исследование выполнено при поддержке некоммерческой федеральной государственной научной организации — Российского научного фонда (FundRef ID 10.13039/501100006769), грант № 14-25-00052.
Πηγή: Urology Herald; Том 12, № 4 (2024); 14-22 ; Вестник урологии; Том 12, № 4 (2024); 14-22 ; 2308-6424 ; 10.21886/2308-6424-2024-12-4
Θεματικοί όροι: ожирение, androgen receptors, type 2 diabetes mellitus, testosterone replacement therapy, CAG repeat, endothelium, endothelial dysfunction, obesity, андрогеновые рецепторы, сахарный диабет 2 типа, тестостерон-заместительная терапия, CAG-повтор, эндотелий, дисфункция эндотелия
Περιγραφή αρχείου: application/pdf
Relation: https://www.urovest.ru/jour/article/view/916/584; Price MA, Alvarado BE, Rosendaal NTA, Câmara SMA, Pirkle CM, Velez MP. Early and surgical menopause associated with higher Framingham Risk Scores for cardiovascular disease in the Canadian Longitudinal Study on Aging. Menopause. 2021;28(5):484-90. DOI:10.1097/GME.0000000000001729; Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002;87(2):589-98. DOI:10.1210/jcem.87.2.8201; Mulligan T, Frick MF, Zuraw QC, Stemhagen A, McWhirter C. Prevalence of hypogonadism in males aged at least 45 years: the HIM study. Int J Clin Pract. 2006;60(7):762-9. DOI:10.1111/j.1742-1241.2006.00992.x; Boden WE, Miller MG, McBride R, Harvey C, Snabes MC, Schmidt J, McGovern ME, Fleg JL, Desvigne-Nickens P, Anderson T, Kashyap M, Probstfield JL.Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease. Am Heart J. 2020;224:65-76. DOI:10.1016/j.ahj.2020.03.016; Islam RM, Bell RJ, Handelsman DJ, McNeil JJ, Nelson MR, Reid CM, Tonkin AM, Wolfe RS, Woods RL, Davis SR. Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial. Lancet Healthy Longev. 2022;3(2):e109-e118. DOI:10.1016/S2666-7568(22)00001-0; Mederos MA, Bernie AM, Scovell JM, Ramasamy R. Can Serum Testosterone Be Used as a Marker of Overall Health? Rev Urol. 2015;17(4):226-30. PMCID: PMC473566; Kirby M, Hackett G, Ramachandran S. Testosterone and the Heart. Eur Cardiol. 2019;14(2):103-10. DOI:10.15420/ecr.2019.13.1; Veerasamy M, Bagnall A, Neely D, Allen J, Sinclair H, Kunadian V. Endothelial dysfunction and coronary artery disease: a state-of-the-art review. Cardiol Rev. 2015;23(3):119-29. DOI:10.1097/CRD.0000000000000047; Khripun IA, Vorobyev SV, Morgunov MN, Kogan MI. Endothelial function in men with type 2 diabetes without clinical signs of cardiovascular disease. Diabetes mellitus. 2016;19(5):383-7. DOI:10.14341/DM8017; Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017;9(5):434-49. DOI:10.1111/1753-0407.12521; Cyr AR, Huckaby LV, Shiva SS, Zuckerbraun BS. Nitric oxide and endothelial dysfunction. Crit Care Clin. 2020;36(2):307-21. DOI:10.1016/j.ccc.2019.12.009; Dubsky M, Veleba J, Sojakova D, Marhefkova N, Fejfarova V, Jude EB. Endothelial dysfunction in diabetes mellitus: new insights. Int J Mol Sci. 2023;24(13):10705. DOI:10.3390/ijms241310705; Lorigo M, Mariana M, Lemos MC, Cairrao E. Vascular mechanisms of testosterone: the nongenomic point of view. J Steroid Biochem Mol Biol. 2020;196:105496. DOI:10.1016/j.jsbmb.2019.105496; Hotta Y, Kataoka T, Kimura K. Testosterone deficiency and endothelial dysfunction: nitric oxide, asymmetric dimethylarginine, and endothelial progenitor cells. Sex Med Rev. 2019;7(4):661-68. DOI:10.1016/j.sxmr.2019.02.005; Sansone A, Rastrelli G, Cignarelli A, de Rocco Ponce M, Condorelli RA, Giannetta E, Maseroli E, Pinto S, Salzano C, Santi D. Effect of treatment with testosterone on endothelial function in hypogonadal men: a systematic review and meta-analysis. Int J Impot Res. 2020;32(4):379-86. DOI:10.1038/s41443-019-0163-6; Online Mendelian Inheritance in Man® (OMIM®). OMIM® Database [Internet]. *313700 Androgen receptor (AR) gene-phenotype relationships. Baltimore (MD), the USA: McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine. ©1966 – 2023. [cited 2022 Oct 17]. Available from: https://www.omim.org/entry/313700.; Gerald T, Raj G. Testosterone and the androgen receptor. Urol Clin North Am. 2022;49(4):603-14. DOI:10.1016/j.ucl.2022.07.004; Aurilio G, Cimadamore A, Mazzucchelli R, Lopez-Beltran A, Verri E, Scarpelli M, Massari F, Cheng L, Santoni M, Montironi R. Androgen receptor signaling pathway in prostate cancer: from genetics to clinical applications. Cells. 2020;9(12):2653. DOI:10.3390/cells9122653; Walker WH. Androgen actions in the testis and the regulation of spermatogenesis. ADV Exp Med Biol. 2021;1288:175-203. DOI:10.1007/978-3-030-77779-1_9; McEwan IJ, Brinkmann AO. Androgen physiology: receptor and metabolic disorders. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al. editor(s). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2021.; Zitzmann M, Brune M, Kornmann B, Gromoll J, von Eckardstein S, von Eckardstein A, Nieschlag E. The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasore-activity. J Clin Endocrinol Metab. 2001;86(10):4867-73. DOI:10.1210/jcem.86.10.7889; Khripun IA, Vorobyev SV, Kogan MI. Association of the polymorphism in the androgen receptor gene and endothelial function in men with type 2 diabetes. Diabetes mellitus. 2015;18(4):35-40. DOI:10.14341/DM7622; Stanworth RD, Akhtar S, Channer KS, Jones TH. The role of androgen receptor CAG repeats polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 substudy. Eur J Endocrinol. 2013;170(2):193-200. DOI:10.1530/EJE-13-0703; Khripun IA, Morgunov MN, Vorobyev SV, Terentiev VP, Kogan MI. Endothelial dysfuncton and 2 type diabetes: novel markers for earlier diagnostics. Cardiovascular Therapy and Prevention. 2016;15(5):59-63. DOI:10.15829/1728-8800-2016-5-59-63; Heald AH, Yadegar Far G, Livingston M, Fachim H, Lunt M, Narayanan RP, Siddals K, Moreno G, Jones R, Malipatil N, Rutter M, Gibson M, Donn R, Hackett G, Jones H. Androgen receptor-reduced sensitivity is associated with increased mortality and poorer glycemia in men with type 2 diabetes mellitus: a prospective cohort study. Cardiovasc Endocrinol Metab. 2020;10(1):37-44. DOI:10.1097/XCE.0000000000000230; Möhlig M, Arafat AM, Osterhoff MA, Isken F, Weickert MO, Spranger J, Pfeiffer AF, Schöfl, C. Androgen receptor CAG repeat length polymorphism modifies the impact of testosterone on insulin sensitivity in men. European journal of endocrinology. 2011;164(6):1013-8. DOI:10.1530/EJE-10-1022; Malavige LS, Jayawickrama S, Ranasinghe P, Levy JC. Androgen receptor CAG repeat polymorphism is not associated with insulin resistance and diabetes among South Asian males. BMC Res Notes. 2017;10(1):685. DOI:10.1186/s13104-017-3035-5; Yang D, Tian J, Zhang X, Yu J, Li S, Wang Z, Ma Y, Liu L, Huang Q, Ma R, Wang J, Li X, Jiang M. The polymorphic CAG repeats in exon 1 of androgen receptor is associated with level of HDL cholesterol and hypertension in Chinese middle-aged and elderly men. Clin Endocrinol (Oxf). 2017;87(1):29-34. DOI:10.1111/cen.13326; Khripun IА, Vorobyev SV. Endothelial function status in hypogonadal men. Diabetes Mellitus. 2021;24(5):440-7. DOI:10.14341/DM12780; https://www.urovest.ru/jour/article/view/916
-
2Academic Journal
Συγγραφείς: КОПЫЛОВА И.В., СЫСОЕВА В.Ю., ГЛЫБИНА Т.М., КАРЕВА М.А.
Περιγραφή αρχείου: text/html
-
3Academic Journal
Πηγή: Проблемы эндокринологии.
Θεματικοί όροι: 03 medical and health sciences, 0302 clinical medicine, ВРОЖДЕННАЯ ДИСФУНКЦИЯ КОРЫ НАДПОЧЕЧНИКОВ,CONGENITAL ADRENAL HYPERPLASIA,ФЕМИНИЗИРУЮЩАЯ ПЛАСТИКА,FEMINIZING GENITOPLASTY,ЭСТРОГЕНОВЫЕ РЕЦЕПТОРЫ,ESTROGEN RECEPTORS,АНДРОГЕНОВЫЕ РЕЦЕПТОРЫ,ANDROGEN RECEPTORS,НАРУЖНЫЕ ПОЛОВЫЕ ОРГАНЫ,EXTERNAL GENITALIA, 3. Good health
Περιγραφή αρχείου: text/html
-
4Academic Journal
Συγγραφείς: Honcharenko, G. Y.
Θεματικοί όροι: adenomyosis, postmenopause, estrogen receptors, progesterone receptors, androgen receptors, аденоміоз, постменопауза, естрогенові рецептори, прогестеронові рецептори, андрогенові рецептори, аденомиоз, эстрогеновые рецепторы, прогестероновые рецепторы, андрогеновые рецепторы
Περιγραφή αρχείου: application/pdf
-
5
Συγγραφείς: Гончаренко, Г. Ю., Goncharenko, G. Yu., Гончаренко, А. Ю.
Θεματικοί όροι: аденоміоз, постменопауза, естрогенові рецептори, прогестеронові рецептори, андрогенові рецептори, adenomyosis, postmenopause, estrogen, progesterone, androgen receptors, аденомиоз, эстрогеновые, прогестероновые, андрогеновые рецепторы
Περιγραφή αρχείου: application/pdf
Relation: Гончаренко Г. Ю. Морфологічні особливості аденоміозу в постменопаузі : автореф. дис. на здобуття наук. ступеня канд. мед. наук : 14.03.02 / Г. Ю. Гончаренко. – Х., 2008. – 24 с.; https://repo.odmu.edu.ua:443/xmlui/handle/123456789/6112
Διαθεσιμότητα: https://repo.odmu.edu.ua:443/xmlui/handle/123456789/6112
-
6
Συγγραφείς: Гончаренко, Г. Ю., Goncharenko, G. Yu., Гончаренко, А. Ю.
Θεματικοί όροι: аденоміоз, постменопауза рецептори, естрогенові рецептори, прогестеронові рецептори, андрогенові рецептори, adenomyosis, postmenopause, estrogen receptors, progesterone receptors, androgen receptors, аденомиоз, постменопауза, эстрогеновые рецепторы, прогестероновые рецепторы, андрогеновые рецепторы
Περιγραφή αρχείου: application/pdf
Διαθεσιμότητα: https://repo.odmu.edu.ua:443/xmlui/handle/123456789/6109